The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Progress in Childhood Cancer: 50 Years of Research Collaboration, a Report From the Children's Oncology Group
Open accessAbstract
The Children's Oncology Group (COG) recently celebrated the milestone of 50 years of pediatric clinical trials and collaborative research in oncology. Our group had its origins in the four legacy pediatric clinical trials groups: the Children's Cancer Group, the Pediatric Oncology Group, the National Wilms' Tumor Study Group and the Intergroup Rhabdomyosarcoma Study Group which merged in 2000 to form the COG. Over the last 50 years, the survival rates for childhood cancer have risen from 10% to almost 80%. Outcome in Acute Lymphoblastic Leukemia (ALL) has gone from a six month median survival to an 85% overall cure rate. We have modified therapies in most major diseases to induce remission with the least amount of long term sequelae. Here we look back on our advances but also look forward to the next 50 years which will produce even more successful treatments that will be tailored to the specific patient translating the tools of molecular genetics. Experience has clearly proven that everything we know about the diagnosis and management of childhood cancer is a result of research and the dramatic historical decrease in mortality from childhood cancer is directly related to cooperative group clinical research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthay, K. K., Villablanca, J. G., Seeger, R. C., Stram, D. O., Harris, R. E., Ramsay, N. K., Swift, P., Shimada, H., Black, C. T., Brodeur, G. M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910143411601 · Cited by 1,898
Farber, S., Diamond, L. K., Mercer, R. D., Sylvester, R. F., & Wolff, J. A. (1948) · New England Journal of Medicine · doi:10.1056/nejm194806032382301 · Cited by 1,806
Grier, H. E., Krailo, M. D., Tarbell, N. J., Link, M. P., Fryer, C. J. H., Pritchard, D. J., Gebhardt, M. C., Dickman, P. S., Perlman, E. J., Meyers, P. A., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020890 · Cited by 1,328
Self-citationLink, M. P., Goorin, A. M., Miser, A. W., Green, A. A., Pratt, C. B., Belasco, J. B., Pritchard, J., Malpas, J. S., Baker, A. R., Kirkpatrick, J. A., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606193142502 · Cited by 1,204
Intergroup Rhabdomyosarcoma Study-IV: Results for Patients With Nonmetastatic Disease
Crist, W. M., Anderson, J. R., Meza, J. L., Fryer, C., Raney, R. B., Ruymann, F. B., Breneman, J., Qualman, S. J., Wiener, E., Wharam, M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.12.3091 · Cited by 1,087
Self-citationThe Third Intergroup Rhabdomyosarcoma Study.
Crist, W., Gehan, E. A., Ragab, A. H., Dickman, P. S., Donaldson, S. S., Fryer, C., Hammond, D., Hays, D. M., Herrmann, J., & Heyn, R. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.3.610 · Cited by 999
Smith, M., Arthur, D., Camitta, B., Carroll, A. J., Crist, W., Gaynon, P., Gelber, R., Heerema, N., Korn, E. L., Link, M., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.1.18 · Cited by 901
Duffner, P. K., Horowitz, M. E., Krischer, J. P., Friedman, H. S., Burger, P. C., Cohen, M. E., Sanford, R. A., Mulhern, R. K., James, H. E., Freeman, C. R., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306173282401 · Cited by 841
Treatment of Wilms' tumor. Results of the third national Wilms' tumor study
D'angio, G. J., Breslow, N., Beckwith, J. B., Evans, A., Baum, E., Delorimier, A., Fernbach, D., Hrabovsky, E., Jones, B., Kelalis, P., et al. (1989) · Cancer · doi:10.1002/1097-0142(19890715)64:2<349::aid-cncr2820640202>3.0.co;2-q · Cited by 681
Packer, R. J., Goldwein, J., Nicholson, H. S., Vezina, L. G., Allen, J. C., Ris, M. D., Muraszko, K., Rorke, L. B., Wara, W. M., Cohen, B. H., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.7.2127 · Cited by 617
Cited by
Increasing value and reducing waste in biomedical research regulation and management
Salman, R. A.-S., Beller, E., Kagan, J., Hemminki, E., Phillips, R. S., Savulescu, J., Macleod, M., Wisely, J., & Chalmers, I. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62297-7 · Cited by 534
Ivers, N. M., Grimshaw, J. M., Jamtvedt, G., Flottorp, S., O’Brien, M. A., French, S. D., Young, J., & Odgaard-Jensen, J. (2014) · Journal of General Internal Medicine · doi:10.1007/s11606-014-2913-y · Cited by 382
Exploring the ethical and regulatory issues in pragmatic clinical trials
Califf, R. M., & Sugarman, J. (2015) · Clinical Trials · doi:10.1177/1740774515598334 · Cited by 191
Bickman, L. (2020) · Administration and Policy in Mental Health and Mental Health Services Research · doi:10.1007/s10488-020-01065-8 · Cited by 184
Historical Trends in the Use of Radiation Therapy for Pediatric Cancers: 1973-2008
Jairam, V., Roberts, K. B., & Yu, J. B. (2013) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.10.007 · Cited by 120
Metadata
- Authors
- O'Leary, M., Krailo, M., Anderson, J. R., & Reaman, G. H.
- Venue
- Seminars in Oncology
- Publisher
- Elsevier BV
- Published
- 2008-10
- Volume
- 35
- Issue
- 5
- Pages
- 484-493
- ISSN
- 0093-7754 (ISSN-L)
- OpenAlex
- W1966368595
- Cited by
- 293
- References
- 39
- FWCI
- 11.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Progress in Childhood Cancer: 50 Years of Research Collaboration, a Report From the Children's Oncology Group. https://app.cochat.ai/papers/10.1053/j.seminoncol.2008.07.008
- The paper
- O'Leary, M., Krailo, M., Anderson, J. R., & Reaman, G. H. (2008). Progress in Childhood Cancer: 50 Years of Research Collaboration, a Report From the Children's Oncology Group. Seminars in Oncology. https://doi.org/10.1053/j.seminoncol.2008.07.008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.